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Aestract  Recent work from  several  laboratories  has suggested the participation  of interme- 
diate structures in the delivery of adsorbed ligands from  the plasma membrane to lysosomes. 
This report presents subcellular fractionation  studies bearing on the role of these structures in 
adsorptive  pinocytosis of epidermal  growth factor  (EGF), fl-hexosaminidase,  and  low density 
lipoprotein (LDL) by human fibroblasts. Using a two-step Percoll density gradient fractionation, 
we identified  newly internalized  (5 rain)  EGF in  two intermediate density structures that are 
essentially  negative for  plasma  membrane  marker,  and  more  bouyant  than  secondary  lyso- 
somes.  Continued  incubation  for  20  min  resulted  in  transfer  to  (or  conversion  to)  vesicles 
sedimenting  with  secondary  lysosomes.  Internalized  fl-hexosaminidase  and  LDL  behaved 
similarly, appearing first in structures of intermediate density, and later appearing in association 
with  secondary  lysosomes.  Two drugs,  NH4CI  and  monensin,  were found  to  inhibit  ligand 
transfer to the secondary lysosome peak, although they did not inhibit entry of bound ligands 
into  intermediate  density  structures.  Upon  removal  of  both  inhibitors,  internalized  ligands 
were quickly transferred to the secondary lysosome peak. This "transfer process" was faster for 
EGF, than  for  the  other  two  ligands  studied.  We  interpret  these data  to  indicate  that  the 
endocytosis of  these three  ligands,  and  their delivery  to  lysosomes  in  fibroblasts,  proceeds 
through a common  pathway, involving  intermediate  nonlysosomal structures. 
Adsorptive pinocytosis of peptide hormones (1, 2), lysosomal 
enzymes (3), low density lipoprotein (LDL) (4), and asialogly- 
coproteins (5) utilizes high-affinity cell surface receptors spe- 
cific for each ligand. Ligands bind to these receptors which, if 
not preclustered,  rapidly cluster, following binding of ligand, 
into specialized regions of the plasma membrane called coated 
pits (4). Endocytosis occurs at this site, and newly internalized 
ligands appear first in coated vesicles that form as endocytic 
vesicles that pinch off from the plasma membrane. The clathrin 
coat is quickly lost,  and  the ligand-containing  smooth mem- 
brane vesicles, which are cytochemically negative for the ly- 
sosomal activity aryl sulfatase (5),  soon appear in the area of 
the  Golgi  apparatus,  and  later  in  secondary  lysosomes  (4). 
Morphological  studies  of the  internalization  of the  ligands 
insulin, epidermal growth factor (EGF), and a2 macroglobulin 
(6),  as well as the lysosomal enzyme fl-galactosidase (7), have 
led investigators to propose (8) a common nonlysosomal inter- 
mediate structure in the delivery of plasma membrane-bound 
ligand to secondary lysosomes. Recent studies suggest that this 
prelysosomal compartment is acidified (9). 
Kinetic and morphological studies of the uptake of LDL (4), 
lysosomal enzymes  (10),  asialoglycoproteins  (11),  and  high- 
mannose  type  glycoproteins  (12)  have  indicated  that  their 
receptors  are  reutilized  and  participate  in  several  rounds  of 
ligand  internalization.  Exposure  of  cells  to  lysosomotropic 
amines such as NH4CI and chloroquine (10), as well as to the 
ionophore  monensin  (13),  all  of which  have  been  shown  to 
raise the pH of normally acidic intracellular compartments (9, 
14), inhibits receptor recycling and results at least in part in the 
trapping  of cell  surface  receptors  within  an  internal  pool. 
Concomitant  incubation  with  ligand  makes  this  effect even 
more pronounced (13). 
Recently, it was found, using subcellular fractionation tech- 
niques (15), that the internalization of the plant lectin  Wistaria 
floribunda agglutinin by murine fibroblasts, which is also me- 
diated through  coated regions of the plasma membrane (16), 
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demonstrated by subcellular fractionation utilizing a  series of 
two Percoll gradients. These structures are localized in the area 
of the Golgi apparatus, vary in size from 0.2 to 0.4 gm, and are 
empty in appearance. Similar results were obtained in the study 
of the internalization of insulin by rat liver (17).  In this paper 
we  use  similar subcellular fractionation techniques  to  show 
that at least three physiologically important ligands that are 
subject to receptor-mediated endocytosis by human fibroblasts 
share  a  common  pathway  in  their  internalization,  and  we 
conclude that intermediate vesicles play a role in the delivery 
of ligands from the cell surface to secondary lysosomes. 
MATERIALS  AND  METHODS 
Enzyme Assays:  Lysosomal enzyme activities were determined fluoro- 
metrically (18). Substrates were purchased from Sigma Chemical Co. (St. Louis, 
MO). fl-Glucuronidase was measured using 4-methylumbelilferyl-fl-D-glucuro- 
hide at 10 mM in 0.1 M sodium acetate, pH 4.8. fl-Hexosaminidase was assayed 
using 4-methylumbelliferyl-2-acetamide-2-deoxy-fl-O-glucopyranoside  at 5 mM 
in  0.08  M  sodium  phosphate-citrate,  pH  4.4.  Acid  phosphatase activity was 
measured with the substrate 4-methylumbelilferyl phosphate at 1 mM in 0.1 M 
sodium citrate, pH 5.1. fl-Galactosidase activity was determined using the sub- 
strate 4-methylumbelliferyl-fl-D-galactoside  at I mM in 0.08 M citrate-phosphate, 
pH 4.4. a-Mannosidase activity was determined using 4-methylumbelliferyl-fl- 
o-mannoside at 1 mM in 0.05 M citrate, pH 4.0. Assays were carried out with the 
addition of 25 gl of enzyme to 100 gl of substrate, and incubation at 37  ° for 30 
rain.  All  reactions were  carried  out  in  the  presence  of 0.1%  Triton  X-100. 
Reactions were terminated with the addition of 1 ml of 50 mM glycine/NaOH 
at pH 10.5 containing 5 mM EDTA. 
Protein was determined fluorometrically using fluorescamine according to the 
method of Rome et aL (19). Blank values were determined for each fraction by 
assaying an identical Percoll gradient to which no sample was applied. 
NADH reductase activity was determined spectrophotometrially using cyto- 
chrome c as an acceptor according to the method of de Duve et aL (20). 
Lactoperoxidase-catalyzed  Iodination:  Lactoperoxidase-cata- 
lyzed iodination of cell surface proteins was performed as previously described 
(15). Cell viability was determined to be 95% following labeling by trypan blue 
exclusion. 
Pentamannosyl  Phosphate:  Pentamarmosyl phosphate was pre- 
pared as described previously (21). 
Ligands:  Epidermal growth factor (EGF)  was purchased from Sigma 
Chemical Co. (St. Louis, MO). Low density Lipoprotein (LDL) was generously 
donated by Dr. G. Shoeufeld (Lipid Research Center, Washington University). 
Partially purified fl-hexosaminidase was prepared as previously described (22). 
Bovine Serum Albumin-Pentamannosyl Phosphate  Con- 
juga tion:  BSA was conjugated to pentamannosyl phosphate (BSA-PMP) by 
a  modification of the method of Schwartz and Gray (23). To  l  ml of 50 mM 
bicine pH 8.6 was added 5 mg of BSA (Sigma Chemical Co., St. Louis, MO), 
pentamannosyl phosphate to 0.2 M, and 5 mg of NaCNBH3 (Sigma Chemical 
Co., St. Louis, MO). The mixture was incubated for 24 h at 37  °. An additional 
5  mg  of NaCNBH3  was  then  added  and  the  incubation  continued  for  an 
additional 24 h  at 37°C. The solution was then extensively dialyzed against 20 
mM sodium phosphate, 0.12 M NaCl, pH 7.0. 
tigand  Iodination:  All  ligands were  iodinated using insolubilized 
lactoperoxidase and glucose oxidase  (Bio-Rad  Laboratories, Richmond, CA) 
according to the manufacturer's recommendations. ~25I was obtained from New 
England Nuclear (Boston, MA) as carrier-free Na 1~51. 
Cells and Cell  Culture:  Normal human lung fibroblasts IMR  91 
(Institute for Medical Research, Camden, N J) and ,6'-hexosaminidase-deficient 
human  skin  fibroblasts WG  98/EW  (Repository  for  Mutant  Human  Cells, 
Montreal, Canada) were used between passages 12 and 18. Cells were cultured 
in 10-cm diameter petri dishes (Scientific Products Co., Evanston, [L) in Eagle's 
minimum essential medium (MEM) plus 15% heat-inactivated fetal bovine serum 
at 37°C and pyruvate, penicillin, and streptomycin in an atmosphere of 5% COs. 
All cells were used 2-4 d after reaching confluence. 
Internalization  Studies:  Cells  were incubated with ligands under 
varying conditions in 2.5 ml of MEM. Incubations with EGF were conducted at 
20 ng/ml at a specific activity of 20,000 cpm/ng. Incubations with ~I-LDL were 
conducted at 1/~g/ml at a specific activity of 100,000 cpm/#g, fl-Hexosaminidase 
uptake was conducted at 4000 U/ml. Incubations with BSA-PMP were conducted 
at l0 ttg/ml at a specific activity of 50,000 cpm/#g. 
When NH4CI was employed, it was added to ceils at  10 mM  in 2.5 ml of 
MEM  15 minutes before addition of the ligand. In studies employing 50 pM 
monensin, ligand and drug were added to the ceils simultaneously. 
Cells used for studies of LDL internalization were incubated 24 h  before use 
in Waymouth's medium without serum. 
Subcellular  fractionation:  Fractionation was conducted using the 
self-forming gradient medium Percoll (Pharmacia Inc., Piscataway, N J) by using 
the method of Merion et al. (15). Cell monolayers were washed three times in 5 
ml of 0.25 M  sucrose plus  1 mM  EDTA (HM) adjusted to pH 7.0 with  1 M 
KOH. Cells were then scraped from the dish with a  rubber policeman in HM 
and homogenized with a Polytron (Brinkman, Luzern, Switzerland) in 1.0 ml of 
HM until -50% of the cells were disrupted as judged by phase contrast micros- 
copy. The resulting homogenate was then subjected to centrifugation at 800 g for 
10 rain, the supernatant reserved, and the pellet washed in HM. The supernatants 
were combined (1.5 ml) and layered on 9 ml of Percoll solution in HM with a 
density of 1.07 g/ml. Samples were subjected to centrifugation at 33,000 g for 50 
min with a 50 Ti rotor in a Beckman L2-ultracentrifuge (Beckman Instruments, 
Palo Alto, CA). Fractions (0.4 ml) were collected by upward flow displacement 
in a Buchler fractionator (Buchler Instruments Inc., Fort Lee, NH). Aliquots (0.3 
ml) of fractions 8-13 from this first gradient were combined and 0.5 ml of HM 
was added. This sample was apphed to 8 ml of a Percoll solution in HM with a 
density of 1.044 g/ml and subjected to centrifugation at 33,000 g  for 20 min to 
produce  a  second  gradient.  Fractions (0.4  ml)  were  collected  as  above.  All 
experiments were repeated at least three times, and representative experiments 
are presented in all figures. 
Gamma Determination:  12'~I was determined with a Packard model 
5260 autogamma counter (Packard Instrument Co., Downers Grove, 1L). 
RESULTS 
First Percoll Density Fractionation 
In order to examine the interaction of ligands with human 
fibroblasts, we employed the Percoll density gradient fraction- 
ation seen in Fig.  1.  In a density  range of 1.035-1.080 g/ml, 
lysosomal enzyme activities are distributed within three peaks. 
A  small amount of activity is found at the top of the gradient 
(fractions  1-3) where soluble substances are localized (15,  19). 
A second peak of activity is localized at a peak modal density 
of 1.040 g/ml (fractions 8-13) and has been suggested by Rome 
et  at.  (19)  to  contain  GERL-derived  structures.  Lysosomal 
enzyme  activity  in  this  peak  may  also  be  due  to  enzyme 
associated  with  endoplasmic  reticulum,  Golgi  and  plasma 
membrane,  since  plasma membrane  and endoplasmic  reticu- 
lure markers also migrate at a peak modal density of 1.040 g/ 
ml (fractions 8-13) and previous work (15,  19) has shown that 
the Golgi marker galactosyl transferase is also localized here. 
The  majority  of lysosomal  enzyme activity  is  localized  at  a 
peak modal density of 1.070 g/ml  (fractions 21-25),  and has 
been shown to contain typical secondary lysosomes (15,  19). 
Internalization of EGF and Transfer to Secondary 
Lysosomes 
In  order  to  examine  EGF  binding  to  human  fibroblasts 
without internalization, we incubated 125I-EGF (20 ng/ml) with 
monolayer cultures at 4°C. Under these conditions EGF binds 
to cell surfaces, and the binding was >90% inhibitable  in the 
presence  of a  100-fold  excess  of unlabeled  ligand  (data  not 
shown). 125I-EGF previously bound to cell surfaces at 4°C was 
>85% elutable  by briefly washing cells at 4°C with buffer at 
pH  3.0 while  retaining  cell viability  (data not shown)  as re- 
ported  previously  by  Haigler  et  al.  (24).  When  cells  were 
incubated with 125I-EGF for 10 min at 37°C, and then subjected 
to an acid wash, only 30% of cell-associated radioactivity was 
removed.  Thus,  >60%  of the cell-associated  activity after  10 
min at 37°C is internalized EGF.  Fig. 2 presents the radioac- 
tivity  profiles  from  cells  fractionated  with  the  first  Percoll 
gradient (as in Fig. 1) 10-30 min after exposure to ~2gI-EGF. In 
Fig. 2A (10 rain),  a small amount of radioactivity is found at 
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FIGURE  I  First  PercoH density gradient fractionation. Normal  hu- 
man fibroblasts in monolayer  culture were iodinated using soluble 
lactoperoxidase at 4°C. A postnuclear supernatant (PNS) was then 
prepared and subjected to density gradient separation as described 
in  Materials  and  Methods.  Fractions (0.4 ml)  were collected  by 
upward  flow displacement and activities determined.  The density 
gradient varies from 1.035 to 1.080  g/ml. 
the top of the gradient (fractions 1-3) where soluble substances 
are localized, but the majority of the remaining radioactivity is 
localized  at  a  peak  modal  density  of 1.040  g/ml  (fractions 
8-13). When incubation was continued for 20 min (Fig. 2B) 
EGF was seen in these two positions of the gradient (as in Fig. 
2A), and also in a new peak of radioactivity at a peak modal 
density of 1.070 g/m1 (fractions 21-25), migrating with second- 
ary lysosomes. Continued incubation of 125I-EGF with cells for 
30 min (Fig. 2 C) shows a progressive increase in the fraction 
of internalized 125I-EGF associated with secondary lysosomes. 
Prior studies of the internalization of the lectin  Wistariaflori- 
bunda agglutinin by murine fibroblasts using similar subceUu- 
lar fractionation techniques have also shown that the internal- 
ized  ligand  becomes  associated  with  secondary  lysosomes 
within 30 min of incubation at 37°C. Morphological analysis 
of fractions containing secondary lysosomes from cells incu- 
bated with a  ferritin-labeled lectin for 30 min at 37°C shows 
that  WFA is  contained  within  structures  with  the  apparent 
morphology of secondary lysosomes (15,  16). 
The experiments discussed above showed substantial transfer 
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of t25I-EGF to secondary lysosomes within  30 min at 37°C. 
We next examined both the temperature  dependence of this 
transfer and the effects of two drugs known to affect receptor 
mediated endocytosis. Fig. 3 A and B show that no transfer to 
the lysosomal peak occurs during a  30-minute incubation at 
either 4°C (Fig. 3A) or 17°C (Fig. 3B). Thus, the transfer is 
temperature-dependent.  A  similar  inhibition  of transfer  was 
observed for the transport of internalized asialoglycoproteins 
to lysosomes by liver hepatocytes (5). Fig. 3 C shows that very 
little  transfer  occurs in  30  min  at  37°C  in  the  presence  of 
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FIGURE 2  Internaliza- 
tion  of  ~2~I-EGF in  the 
first  density  gradient 
fractionation.  Normal 
human fibroblasts were 
incubated with 1251-EGF 
(20  ng/ml)  in  serum- 
free media at 37°C for: 
(A)  10 rain; (B) 20 rain; 
(C)  30 min. Cells were 
then  subjected  to den- 
sity gradient separation 
as  in  Fig.  I  and  radio- 
activity  was  deter- 
mined. 
FIGURE  3  Normal  human 
fibroblasts  were subjected 
to  density  gradient  frac- 
tionation  as  in  Fig.  1  fol- 
lowing  incubation  with 
1251-EGF  under  varying 
conditions.  (A)  4°C;  (B) 
17°C; (C) 37°C in the pres= 
ence of 10 mM NH4CI; (D) 
37°C in the presence of 50 
/~M monensin. NH4C1.  Under these  conditions, the rate of accumulation of 
cell-associated EGF was not affected, but the ligand localized 
in lighter density fractions. Similarly, incubations of cells with 
~25I-EGF for 30  rain  at  37°C  in  the  presence  of monensin 
resulted in the inhibition of transfer of ligand to the lysosomal 
peak. None of these treatmetlts significantly affected the lyso- 
somal enzyme distribution in these gradients. 
To determine whether 125I-EGF internalized in the presence 
of NI-hCI and monensin could be transferred from these com- 
partments  to secondary lysosomes when  the  drugs were  re- 
moved, we allowed cells to accumulate 125I-EGF for 30 min in 
the presence of the drugs and  fractionated them at different 
time intervals following their removal. However, to eliminate 
cell surface bound EGF, we washed the cells briefly at pH 3.0 
before the postincubation. This treatment removed 30% of cell- 
associated radioactivity in both cases, indicating that at least 
60% of cell-associated radioactivity was contained within some 
intracellular compartment. Cells were then harvested immedi- 
ately (Fig. 4A and B) or following postincubation in serum- 
free media for 15 (Fig. 4A and B), and 30 (Fig. 4A and B) 
min.  Ceils  harvested  immediately  following incubation  with 
EGF and drugs showed that very little ligand had entered the 
lysosomal peak as was the case in the experiment seen in Fig. 
3. However, 15 rain following the removal of the drug and the 
ligand, ~ 50% of cell-associated radioactivity was localized with 
secondary lysosomes (fractions 21-25).  After 30-min incuba- 
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FIGURI:  4  Transfer  of  1251-EGF to  secondary lysosomes following 
removal  of  inhibitors.  Normal  human  fibroblasts were  incubated 
with  12SI-EGF (20 ng/ml)  in serum-free media at 37°C in the pres- 
ence of 10 mM NH4CI  (A) and 50#M monensin (B). Cultures were 
then washed in buffer at pH 3.0 for 5 rain at 4°C to remove plasma 
membrane-bound ligand and either harvested immediately (0 time 
postincubation), or incubated at 37°C in  serum-free  media for 15 
(15 rain postincubation) and 30 (30 min postincubation) min. Cells 
were then subjected to density gradient separation as in  Fig. 1 and 
radioactivity was determined. In  each frame the time,  postincuba- 
tion, is given. 
tion following removal of the drugs and the ligand,  -70% of 
cell-associated radioactivity was localized with secondary ly- 
sosomes. Thus, the inhibition of transfer of EGF from inter- 
mediate vesicles to lysosomes by these two drugs is reversible. 
Transfer of t~-hexosaminidase,  125 I-BSA-PMP, 
and 12~I-LDL  into Secondary Lysosomes 
In order to examine other ligand  receptor systems, we se- 
lected the  internalization  of fl-hexosaminidase  by fl-hexosa- 
minidase-deficient  fibroblasts  and  t25I-BSA-PMP by normal 
human fibroblasts for study of the phosphomannosyl receptor 
system, fl-Hexosaminidase internalization was chosen because 
it represents the pathway of a physiological ligand.  125I-BSA- 
PMP internalization was chosen to examine the same pathway 
in  normal  (i.e.,  not fl-hexosaminidase  deficient)  fibroblasts. 
125I-LDL internalization by normal human fibroblasts was also 
chosen  for  study  because  this  pathway  represents  the  best 
characterized of receptor-mediated  endocytosis pathways.  In 
these  experiments  an  approach  similar  to  that  used  for the 
study of EGF internalization was employed. Cells were incu- 
bated with fl-hexosaminidase  (Fig.  5A),  ~25I-BSA-PMP  (Fig. 
5 B), and t25I-LDL (Fig. 5 C) for 30 min at 37°C in the presence 
of 10 mM NI-I4C1 and either fractionated immediately follow- 
ing the incubation (Fig. 5, 0 time postincubation), or following 
a postincubation in serum-free media at 37°C for 15 (Fig. 5, 15 
min.  Postincubation)  or 30 (Fig.  5,  30 min.  Postincubation) 
minutes.  In all cases ligand was found with  secondary lyso- 
somes (fractions 21-25) at 30-, but not 15-rain postincubation 
period. Identical results were obtained when 50 #M monensin 
was  substituted  for NH4CI (data  not  shown).  These  results 
show three  things: (a) Both NH4C1  and monensin block the 
accumulation of ~25I-EGF within typical secondary lysosomes. 
(b) Transfer of internalized ligands to lysosomes occurs follow- 
ing removal of drug inhibitors.  (c)  Transfer to lysosomes of 
EGF following removal of drug inhibitors occurs more quickly 
than for the other studied ligands. 
Simultaneous Internalization of 1  251_EG  F and t~- 
Hexosaminidase 
In order to verify the differential  rate  of transfer of EGF 
and fl-hexosaminidase to secondary lysosomes, we incubated 
the  two  ligands  simultaneously with fl-hexosaminidase-defi- 
cient fibroblasts for 30 rain at 37°C in the presence of 10 mM 
NH4C1. Cells were then either harvested immediately following 
this incubation (Fig. 6 A), or following postincubation in serum- 
free media for 15 (Fig. 6B) or 30 (Fig. 6 C) min. Postincubation 
for 15 rain results in EGF localization within secondary lyso- 
somes (Fig. 6 B, fractions 21-25), while a 30-rain postincubation 
is  required  for the appearance  of fl-hexosaminidase  in these 
fractions (Fig. 6 C, fractions 21-25). 
Ligand Internalization Into Intermediate 
Structures 
In order to examine more closely the initial steps of ligand 
internalization, we conducted further fractionation of fractions 
8-13 from the first Percoll gradient (Fig. 1) on a second Percoll 
gradient. The enzymatic profde of this gradient is seen in Fig. 
7. Plasma membrane marker is unimodal in distribution at a 
peak  modal  density  of  1.035  g/ml  (fractions  4-7).  NADH 
reductase activity is distributed in a broad peak between 1.037 
and  1.041 ml (fractions 4-13), as well as in a distinct peak at 
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FIGURE  5  Transfer  of  ,8-hexosa- 
minidase, 1251-BSA-PMP, and 12Sl- 
LDL to secondary lysosomes.  (A) 
/~-hexosaminidase-deficient  hu- 
man  fibroblasts  were  incubated 
with/Lhexosaminidase (4,000 U/ 
ml)  at  37°C  for  30  min  in  the 
presence  of  10  mM  NH4CI.  (B) 
Normal  human  fibroblasts  were 
incubated with  ~2SI-BSA-PMP (10 
p,g/ml)  at 37°C for 30 min  in the 
presence of  10  mM  NHaCl.  (C) 
Normal  human  fibroblasts  were 
incubated with ~251-LDL (1 p.g/ml) 
at 37°C for 30 rain in the presence 
of  10  mM  NHaCI.  Cultures  were 
then harvested immediately or in- 
cubated  at  37°C  in  serum-free 
media for  15 or 30  rain. All ceils 
were  then  subjected  to  density 
gradient separation as in Fig. 1. In 
each frame the time, postincuba- 
tion, is given. 
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Transfer of 12SI-EGF and ,8-hexosaminidase to secondary  FIGURE  6 
lysosomes./~-Hexosaminidase-deficient human fibroblasts were in- 
cubated with 12SI-EGF (20 ng/ml, top panels) and ,8-hexosaminidase 
(4,000 U/ml, bottom panels) at 37°C in serum-free media for 30 rain 
in  the presence of 10 mM  NH4CI.  Cultures were than  either frac- 
tionated immediately (A) as in Fig. 1 or incubated at 37°C in serum- 
free media for 15 (B) or 30 (C) rain and then fractionated as in Fig. 
1. In these experiments, no pH stripping was employed. Radioactiv- 
ity and/~-hexosaminidase activity were then determined. 
1.043 g/ml (fractions 20-24). Lysosomal enzyme activities are 
distributed in a broad peak from 1.035 to 1.041 g/ml (fractions 
4-12) and, with the exception of acid phosphatase, in a second 
peak at 1.045 g/ml (fractions 24-26) that contains between 10 
and 15% of the total activity on the second gradient. 
This fractionation was employed to examine the initial steps 
in the internalization  of EGF by human fibroblasts. 125I-EGF 
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FIGURE  7  Second Percoll density gradient fractionation.  Fractions 
8-13  from  the first gradient as presented in  Fig. 1 were combined 
and subjected to density gradient separation as described in Mate- 
rials and Methods. Fractions (0.4 ml) were collected by upward flow 
displacement  and  activities  determined.  Densities  vary  between 
1.025 and 1.050 g/ml.  Left column, from  top to bottom:/~-hexosa- 
minidase; ,8-galactosidase;  acid phosphatase;/~-glucuronidase. Right 
column,  from  top  to  bottom:  a-mannosidase;  plasma  membrane 
1251; NADH reductase; protein. 
was incubated with normal human fibroblasts at 37°C for 1, 3, 
and 5 min. Cells were fractionated as in Fig. 1, and fractions 
8-13 were pooled and fractionated as in Fig. 7. The profiles of 
radioactivity for the second gradient fractionation are seen in 
Fig, 8. Following  a l-rain incubation, radioactivity is unimodal 
in distribution at a density of 1.035 g/ml (fractions 4-7) and 
migrates in the position seen for plasma membrane marker 
(Fig. 7). Following a 3-rain incubation, in addition to the peak 
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FIGURE 8  Analysis  of 
internalization  of  12~I- 
EGF on the second Per- 
coil  density  gradient. 
Normal  human  fibro- 
blasts  were  incubated 
with  12~I-EGF (20  ng/ 
ml)  in  serum-free  me- 
dia at 37°C for 1, 3, and 
5  min.  In  these experi- 
ments, no pH stripping 
was  employed.  Cells 
were then subjected to 
gradient  separation  as 
in  Fig.  1  (not  shown). 
Fractions  8-13  were 
then  pooled  and  sub- 
jected  to  further  frac- 
tionation  as  in  Fig.  7, 
and  radioactivity  was 
determined. Top, 1 min; 
middle, 3 min; bottom, 
5 min. 
at  1.035  g/ml (fractions 4--7),  radioactivity also appears on a 
shoulder  of this  peak  that  extends  to  1.041  g/ml  (fractions 
8-13),  and  in  an  additional  peak  at  1.043  g/ml  (fractions 
20-23).  Following 5-min incubation three distinct radioactive 
peaks are seen at densities of 1.035 g/ml (fractions 4--7),  1.041 
g/ml  (fractions  10-13),  and at  1.043  g/ml  (fractions  21-25). 
The peak of radioactivity localized at  1.043  g/ml was consis- 
tently  two  to  three  fractions  less  dense  than  the  peak  of 
lysosomal enzyme activity localized at  1.045 g/ml. When ceils 
were incubated with 125I-EGF for 30 min at 17°C and fraction- 
ated as described above, radioactivity peaks were also detected 
at densities of 1.035,  1.041,  and 1.043 g/ml (data not shown). 
To  determine  whether  the  other  ligands  studied  are  also 
internalized into intermediate nonlysosomal structures  labeled 
with EGF, we treated cells with ligand for 30 rain at 37°C in 
the presence of 10 mM NH4C1. Cultures were then fractionated 
as in Fig.  1, and fractions 8-13 pooled and fractionated again 
as in Fig. 7. Activity profiles of this gradient fractionation are 
seen in Fig. 9. Figure 9A shows the distribution of cell-associ- 
ated  /3-hexosaminidase  from B-hexosaminidase-deficient  hu- 
man fibroblasts allowed to internalize the purified enzyme./3- 
Hexosaminidase  activity is localized at  1.035  g/ml (fractions 
4-7), at 1.041 g/ml (fractions 8-12), and at 1.043 g/ml (fractions 
19-23).  Fractionation of normal human fibroblasts incubated 
with ~25I-EGF (Fig. 9 B) shows the same three peaks of radio- 
activity  as with/3-hexosaminidase  (Fig.  9A).  When cells  are 
washed briefly at an acid pH before fractionation (Fig.  9 C), 
the peak of radioactivity at  1.035  g/ml (fractions 4-7) where 
plasma  membrane  marker  is  localized  (Fig.  7)  is  removed. 
Fractionation of normal human fibroblasts incubated with 1251- 
LDL is seen in Fig. 9 D. Again, ligand is localized at densities 
of 1.035,  1.041,  and 1.043 g/ml. Thus, all three ligands appear 
to enter and accumulate in both of the intermediate compart- 
ments in the presence of NH4CI. 
DISCUSSION 
These studies  illustrate  four important points that  merit dis- 
cussion: (a) The three physiological ligands fl-hexosaminidase, 
EGF, and LDL are internalized by human fibroblasts into two 
prelysosomal  intermediate  structures  that  can be  isolated  by 
density  gradient  subcellular  fractionation.  (b)  Ligands  are 
transferred  from  these  intermediate  structures  to  secondary 
lysosomes. (c) This "transfer"  is inhibited  in the presence of 
both NI-hCI and monensin and is reversible upon removal of 
the drug. (d) Upon removal of drug inhibitors, EGF is trans- 
ferred from intermediates  to lysosomes faster than the  other 
studied ligands. 
The two-step Percoll density gradient separation permitted 
us  to  demonstrate  EGF  quite  clearly  in  two  prelysosomal 
intermediates.  These  two  structures  differ  slightly  in  density 
and  are  localized  in  areas  of the  density  gradient  that  are 
essentially negative for plasma membrane marker. Both struc- 
tures  are  also more bouyant than  secondary lysosomes.  The 
heavier of the two intermediates is almost completely lacking 
in lysosomal enzyme markers, while the area of the gradient 
containing the lighter intermediate contains a small amount of 
lysosomal  enzyme activity.  This  activity  may be  due  to  the 
association of lysosomal enzymes with co-migrating endoplas- 
mic  reticulum  and/or  GERL.  Alternatively,  lysosomal  en- 
zymes may be contained within intermediate structures,  which 
could  be  involved in  the  transport  of newly  synthesized en- 
zymes to lysosomes. These structures  were also seen to contain 
internalized fl-hexosaminidase,  a ligand for the phosphoman- 
nosyl receptor,  and internalized  LDL. Thus,  although we do 
not show directly that ligands are internalized within the same 
vesicles,  the internalization of three physiological ligands ap- 
pears to proceed through a common pathway. Previous studies 
on the  internalization  of the plant  lectin  Wistaria  floribunda 
agglutinin (WFA) have shown that this ligand also shares this 
endocytic pathway (15).  In that study,  morphological exami- 
8 
~6 
~4 
i  I  i  I  I  1  i 
A. 
B. 
C. 
D. 
8 
6 
4 
Z 
0  8  16  24 
FRACTION  NUMBER 
A  J 
~7  1.06 ~  t 
1.-  i 
1.04 ~  ,,.~t 
1.02~ 
FIGURE 9  Second  Per- 
coil  density  gradient 
analysis  of  internaliza- 
tion  of  ,8-hexosamini- 
dase, ~2St-EGF, and ~2Sl- 
LDL  into  intermediate 
structures.  ,6'-  Hexosa- 
minidase-deficient  hu- 
man  fibroblasts  were 
incubated  with  ,B-hex- 
osaminidase  (4,000  U/ 
ml) (A), and normal hu- 
man  fibroblasts  were 
incubated with 12eI-EGF 
(20  ng/ml)  (B and  C), 
and  I~SI-LDL  (1  btg/ml) 
(D)  at 37°C for 30 min 
in  the  presence  of  10 
mM  NH4CI.  Cells  in  C 
were  then  washed  at 
4°C  in  buffer at pH 3.0 
for  5  min.  All  cultures 
were then subjected to 
density  gradient  sepa- 
ration  as in  Fig.  1  (not 
shown).  Fractions 8-13 
from  these  fractiona- 
tions  were  then  com- 
bined and  subjected to 
further  fractionation  as 
in  Fig.  7. ,B-Hexosamin- 
idase  and  radioactivity 
were then  determined. 
A, ,B-hexosaminidase;  B, 12eI-EGF;  C, 12~I-EGF  plus Gly/HCI;  D, ~251- 
LDL 
M[RION AND  SLY  Role  of Intermediate  Vesicles  649 nation of fractions containing internalized lectin-ferritin  con- 
jugate  revealed  that ligand-containing  vesicles,  derived from 
an area of the density gradient containing intermediate struc- 
tures, were bound by a single smooth membrane and varied in 
diameter from 0.2 to 0.4 #M (16). 
These structures  appear to be true intermediates in receptor- 
mediated endocytosis and delivery of ligand to lysosomes. This 
was dearly demonstrated  by removing the ligand  associated 
with the cell surface and showing that the internalized ligands 
in the intermediates  moved to the lysosomal peak on subse- 
quent incubation. 
Treatment of cells with ligand in the presence of NH4CI or 
monensin,  drugs  known to  raise  the  pH  of normally  acidic 
intracellular compartments (10, 13, 14), inhibits the appearance 
of ligand within the dense peak of lysosomal enzyme activity. 
This may be  due to (a)  inhibition  of fusion  of intermediate 
structures  with  lysosomes,  or  (b)  inhibition  of a  subsequent 
step  in  which  the  fusion  product  of  the  intermediate  and 
lysosomes, which is presumably more buoyant than lysosomes, 
fails to undergo the reduction in volume and/or increase  in 
density required to sediment with secondary lysosomes, or (c) 
failure  of the  ligand  to  dissociate  from  the  receptor  in  the 
prelysosomal compartment, with consequent failure to segre- 
gate with soluble content markers into lysosomes. The results 
presented here do not distinguish these alternatives. 
The slower rates  of transfer  of LDL and acid hydrolases to 
lysosomes than are seen for EGF were unexpected. This may 
reflect  a requirement for these ligands to first dissociate from 
their receptors to be delivered to lysosomes. This dissociation 
would be both time and pH dependent. Such dissociation from 
the receptor may not be required  for EGF  delivery to lyso- 
somes, as this receptor does not recycle back to the cell surface 
following internalization in most mammalian cell types (2). If 
this interpretation were correct,  it would imply that the disso- 
ciation  of LDL  and  acid  hydrolases  from  their  pinocytosis 
receptors is a prelysosomal rather than a lysosomal event and 
that  the  site  of this  dissociation  may  be  the  intermediates 
demonstrated in this study. 
Isolation  of intermediate  structures  that  participate  in  the 
delivery of bound ligand from the plasma membrane to lyso- 
somes provides the opportunity to examine in detail the process 
of  ligand-receptor  dissociation,  as  well  as  the  factors  that 
regulate the recycling and degradation of receptors. 
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